A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
No existe un tratamiento específico para el síndrome de Lesh-Nyhan. El medicamento para la gota alopurinol disminuye eficazmente los niveles de ácido úrico, pero no mejora el pronóstico neurológico.
Algunos síntomas se pueden aliviar con los medicamentos carbidopa o levodopa, diazepam, fenobarbital o haloperidol.
El pronóstico probablemente sea desalentador. Las personas con este síndrome por lo general requieren ayuda para caminar y sentarse y normalmente necesitan una silla de ruedas para movilizarse.
Es probable que se presente discapacidad progresiva y severa.
La persona debe consultar con el médico si su hijo comienza a presentar signos de esta enfermedad o si hay antecedentes familiares del síndrome de Lesch-Nyhan.
Harris JC. Disorders of purine and pyrimidine metabolism. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 89.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885